Home LiteratureArticle Details
PMID: 11304461 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

HDL and the inflammatory response induced by LDL-derived oxidized phospholipids.

Arteriosclerosis, thrombosis, and vascular biology ·Vol. 21 ·No. 4 ·2001-04-00 ·Pages 481-8

Navab M, Berliner JA, Subbanagounder G, Hama S, Lusis AJ, Castellani LW, Reddy S, Shih D, Shi W, Watson AD, Van Lenten BJ, Vora D, Fogelman AM

Abstract

Oxidation of low density lipoprotein (LDL) phospholipids containing arachidonic acid at the sn-2 position occurs when a critical concentration of "seeding molecules" derived from the lipoxygenase pathway is reached in LDL. When this critical concentration is reached, the nonenzymatic oxidation of LDL phospholipids produces a series of biologically active, oxidized phospholipids that mediate the cellular events seen in the developing fatty streak. Normal high density lipoprotein (HDL) contains at least 4 enzymes as well as apolipoproteins that can prevent the formation of the LDL-derived oxidized phospholipids or inactivate them after they are formed. In the sense that normal HDL can prevent the formation of or inactivate these inflammatory LDL-derived oxidized phospholipids, normal HDL is anti-inflammatory. HDL from mice that are genetically predisposed to diet-induced atherosclerosis became proinflammatory when the mice are fed an atherogenic diet, injected with LDL-derived oxidized phospholipids, or infected with influenza A virus. Mice that were genetically engineered to be hyperlipidemic on a chow diet and patients with coronary atherosclerosis, despite normal lipid levels, also had proinflammatory HDL. It is proposed that LDL-derived oxidized phospholipids and HDL may be part of a system of nonspecific innate immunity and that the detection of proinflammatory HDL may be a useful marker of susceptibility to atherosclerosis.

MeSH Terms
Animals Arteriosclerosis/diagnosis,metabolism,physiopathology Biomarkers Coronary Artery Disease/diagnosis,metabolism,physiopathology Diet, Atherogenic Disease Models, Animal Humans Inflammation/metabolism,physiopathology Lipoproteins, HDL/metabolism,physiology Lipoproteins, LDL/metabolism,physiology Lipoxygenase/metabolism,physiology Mice Oxidation-Reduction Phospholipids/metabolism,physiology
Chemicals
Biomarkers Lipoproteins, HDL Lipoproteins, LDL Phospholipids oxidized low density lipoprotein Lipoxygenase
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Navab M
Department of Medicine, UCLA School of Medicine, Los Angeles, CA 90095-1736, USA.
Berliner J A
Subbanagounder G
Hama S
Lusis A J
Castellani L W
Reddy S
Shih D
Shi W
Watson A D
Van Lenten B J
Vora D
Fogelman A M
Article Info
Journal
Arteriosclerosis, thrombosis, and vascular biology
Abbr.
Arterioscler Thromb Vasc Biol
ISSN
1524-4636
Published
2001-04-00
Pages
481-8
Language
English
Region
United States
NLM ID
9505803
Subset
IM
Grants
NHLBI NIH HHS · HL-30568 · United States
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com